BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee IS, Kim KJ, Kang EH, Yu BH. beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder. J Affect Disord 2008;110:156-60. [PMID: 18199486 DOI: 10.1016/j.jad.2007.12.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Vismara M, Girone N, Cirnigliaro G, Fasciana F, Vanzetto S, Ferrara L, Priori A, D'Addario C, Viganò C, Dell'Osso B. Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview. Brain Sci 2020;10:E564. [PMID: 32824625 DOI: 10.3390/brainsci10080564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Hill LK, Sherwood A, McNeilly M, Anderson NB, Blumenthal JA, Hinderliter AL. Impact of Racial Discrimination and Hostility on Adrenergic Receptor Responsiveness in African American Adults. Psychosom Med 2018;80:208-15. [PMID: 29206724 DOI: 10.1097/PSY.0000000000000547] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Shin LM, Davis FC, Vanelzakker MB, Dahlgren MK, Dubois SJ. Neuroimaging predictors of treatment response in anxiety disorders. Biol Mood Anxiety Disord 2013;3:15. [PMID: 23915782 DOI: 10.1186/2045-5380-3-15] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
4 Gundersen V, Storm-Mathisen J, Bergersen LH. Neuroglial Transmission. Physiol Rev 2015;95:695-726. [PMID: 26084688 DOI: 10.1152/physrev.00024.2014] [Cited by in Crossref: 102] [Cited by in F6Publishing: 100] [Article Influence: 17.0] [Reference Citation Analysis]
5 Mchugh RK, Smits JA, Otto MW. Empirically Supported Treatments for Panic Disorder. Psychiatric Clinics of North America 2009;32:593-610. [DOI: 10.1016/j.psc.2009.05.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
6 Brehm JM, Ramratnam SK, Tse SM, Croteau-Chonka DC, Pino-Yanes M, Rosas-Salazar C, Litonjua AA, Raby BA, Boutaoui N, Han YY, Chen W, Forno E, Marsland AL, Nugent NR, Eng C, Colón-Semidey A, Alvarez M, Acosta-Pérez E, Spear ML, Martinez FD, Avila L, Weiss ST, Soto-Quiros M, Ober C, Nicolae DL, Barnes KC, Lemanske RF Jr, Strunk RC, Liu A, London SJ, Gilliland F, Sleiman P, March M, Hakonarson H, Duan QL, Kolls JK, Fritz GK, Hu D, Fani N, Stevens JS, Almli LM, Burchard EG, Shin J, McQuaid EL, Ressler K, Canino G, Celedón JC. Stress and Bronchodilator Response in Children with Asthma. Am J Respir Crit Care Med 2015;192:47-56. [PMID: 25918834 DOI: 10.1164/rccm.201501-0037OC] [Cited by in Crossref: 59] [Cited by in F6Publishing: 32] [Article Influence: 9.8] [Reference Citation Analysis]
7 Bandelow B, Baldwin D, Abelli M, Bolea-Alamanac B, Bourin M, Chamberlain SR, Cinosi E, Davies S, Domschke K, Fineberg N, Grünblatt E, Jarema M, Kim YK, Maron E, Masdrakis V, Mikova O, Nutt D, Pallanti S, Pini S, Ströhle A, Thibaut F, Vaghi MM, Won E, Wedekind D, Wichniak A, Woolley J, Zwanzger P, Riederer P. Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry 2017;18:162-214. [PMID: 27419272 DOI: 10.1080/15622975.2016.1190867] [Cited by in Crossref: 109] [Cited by in F6Publishing: 87] [Article Influence: 21.8] [Reference Citation Analysis]
8 Maron E, Hettema JM, Shlik J. Advances in molecular genetics of panic disorder. Mol Psychiatry 2010;15:681-701. [DOI: 10.1038/mp.2009.145] [Cited by in Crossref: 79] [Cited by in F6Publishing: 60] [Article Influence: 7.2] [Reference Citation Analysis]
9 Caldirola D, Grassi M, Alciati A, Riva A, Sangiorgio E, Daccò S, Perna G. Personalized medicine in panic disorder: where are we now? A meta-regression analysis. Personalized Medicine in Psychiatry 2017;1-2:26-38. [DOI: 10.1016/j.pmip.2016.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Lueken U, Zierhut KC, Hahn T, Straube B, Kircher T, Reif A, Richter J, Hamm A, Wittchen H, Domschke K. Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application. Neuroscience & Biobehavioral Reviews 2016;66:143-62. [DOI: 10.1016/j.neubiorev.2016.04.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 13.6] [Reference Citation Analysis]
11 Perna G, Alciati A, Sangiorgio E, Caldirola D, Nemeroff CB. Personalized Clinical Approaches to Anxiety Disorders. In: Kim Y, editor. Anxiety Disorders. Singapore: Springer; 2020. pp. 489-521. [DOI: 10.1007/978-981-32-9705-0_25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Maron E, Nutt D. Biological predictors of pharmacological therapy in anxiety disorders. Dialogues Clin Neurosci 2015;17:305-17. [PMID: 26487811 [PMID: 26487811 DOI: 10.31887/dcns.2015.17.3/emaron] [Cited by in Crossref: 11] [Article Influence: 2.2] [Reference Citation Analysis]
13 Bosker FJ, Gladkevich AV, Pietersen CY, Kooi KA, Bakker PL, Gerbens F, den Boer JA, Korf J, te Meerman G. Comparison of brain and blood gene expression in an animal model of negative symptoms in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012;38:142-8. [DOI: 10.1016/j.pnpbp.2012.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]